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ADVANCES IN MASS SPECTROMETRY-BASED PROTEOMICS
IMPACT THE ANALYSIS OF BACTERIAL PTMS
Post translational modifications (PTMs) play a vital role in maintaining protein function,
regulation, signaling, and many other important cellular processes (Anonsen et al., 2012). For
several years, protein PTMs were thought to be unique to eukaryotes; only recently it has been
demonstrated that bacteria also contain a wide variety of PTMs including those previous described
in eukaryotic cells, for example Ser/Thr/Tyr phosphorylation, lysine-acetylation, glycosylation,
ubiquitination, and glutathionylation, as reviewed (Macek and Mijakovic, 2011; Soufi et al., 2012;
Michard and Doublet, 2015; Ravikumar et al., 2015). PTMs have been linked to numerous
essential bacterial cellular events, including cell division, morphology, and more recently they
have also been associated with: Pathogenicity (Michard and Doublet, 2015; Ravikumar et al.,
2015); virulence (Lin et al., 2009; Calder et al., 2015; Fortuin et al., 2015); and drug resistance
(Soares et al., 2014; Lai et al., 2016). The employment of powerful new proteomics platforms has
contributed to significant insight in to the regulatory functions of bacterial PTMs. More than a
decade ago, the first attempts to catalog bacterial phosphoproteomes were performed using 2D
gel electrophoresis-based (2-DE) approaches, first combined with 33P radiolabelling and later with
phosphoprotein-specific dyes (Cortay et al., 1986; Bendt et al., 2003; Lévine et al., 2006). However,
such studies were limited by a number of technical challenges, including those inherent to gel
based approaches (Pietrogrande et al., 2003; Monteoliva and Albar, 2004). Consequently, at the
time few phosphoproteins and even fewer phosphorylation sites were reported. As the field of
proteomics progressed from 2-DE gel based methodologies to modern liquid chromatography
mass-spectrometry (LC-MS/MS) based workflows, significant advances in the analysis of bacterial
PTMs were then achieved. The introduction of modern mass spectrometry (MS), specifically the
inclusion of Orbitrap mass spectrometers, brought new momentum to the field. In 2006, Mann
and colleagues proposed a gel-free approach to explore the phosphoproteome of eukaryotic cells
in depth. The study reported the identification of more than 6600 phosphorylation sites (Olsen
et al., 2006). Their workflow involved the enzymatic digestion of complex protein extracts into
peptides and then phosphopeptides were enriched by a combination of strong cation exchange
and TiO2 chromatography. Macek et al. (2007) used similar technology to describe a site–
specific, in vivo phosphoproteome of a gram positive model organism, Bacillus subtilis. The study
represented a main breakthrough in the bacterial phosphoproteomic field: the number of reported
B. subtilis phosphoproteins went from 16 phosphorylation sites on eight proteins to 103 unique
phosphopetides on 78 proteins (Macek et al., 2007). This order of magnitude jump in the field
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then inspired many other subsequent studies that successfully
applied variants of the protocol described by Macek et al. (2007),
in particular those that employed phosphopetide enrichment via
immobilized metal affinity chromatography (IMAC; Thingholm
and Jensen, 2009) to perform high throughput analysis of
different bacterial phosphoproteomes (Ravichandran et al., 2009;
Qu et al., 2013). Today, several bacterial phosphoproteomes have
been successfully characterized including some important
human pathogenic bacteria: Pseudomonas aeruginosa
(Ravichandran et al., 2009); Klebsiella pneumoniae (Lin
et al., 2009); mycobacterium spp. (Prisic et al., 2010; Fortuin
et al., 2015; Nakedi et al., 2015; Calder et al., 2016); Helicobacter
pylori (Ge et al., 2011), streptomyces spp. (Manteca et al., 2011);
Acinectobacter baummnii (Soares et al., 2014; Lai et al., 2016);
Staphylococcus aureus (Basell et al., 2014); and Enteropathogenic
Escherichia coli (Scholz et al., 2015). The development of new
high throughput mass spectrometric instrumentation (Michalski
et al., 2011b, 2012; Scheltema et al., 2014; Erickson et al., 2015)
together with continuous optimization of LC-MS/MS shotgun
proteomics workflows (Michalski et al., 2011a; Kelstrup et al.,
2012; Pirmoradian et al., 2013) resulted in increased resolution,
sensitivity, and fragmentation and has contributed to the
successful identification and localisation of phosphosites. Such
approaches have also now allowed for the identification of other
bacterial PTMs such as lysine acetylation (Zhang et al., 2009;
Weinert et al., 2013; Wu et al., 2013; Liu et al., 2014; Ouidir et al.,
2015; Xie et al., 2015), ubiquitination (Valkevich et al., 2014), and
glycosylation (Scott et al., 2011; Anonsen et al., 2012; Smith et al.,
2014). It is therefore well established that large scale LC-MS/MS
shotgun proteomics is the technique of choice for identifying
bacterial post-translationally modified peptides/proteins.
When quantifying the state of a modified peptide/protein
under a certain experimental condition(s) and/or during
different cellular processes, it is important to determine its
regulatory function and ultimately link this to a specific
molecular mechanism. Recent advances in quantitative LC-
MS/MS based proteomics have made possible the reliable
quantification of thousands of phosphorylation peptides in
eukaryotic cells (Pan et al., 2008) and, likewise, a number of
studies have successfully applied different quantificationmethods
to describe the dynamics of bacterial phosphoproteomes under
different cellular states or experimental conditions. For instance,
stable isotope labeling by amino acids in cell culture (SILAC)
has recently been applied to establish the dynamics of both the
proteome and phosphoproteome of E. coli during five different
growth phases in liquid cell culture (Soares et al., 2013). In that
study, 76 Ser/Thr/Tyr phosphorylation events were quantified
in all growth phases. Importantly the use of SILAC enabled
the measurement of median occupancies of phosphorylation
sites, which, unlike eukaryotic cells (Pan et al., 2008), were
generally low (<12%) (Soares et al., 2013). SILAC has been
successfully used on a number of occasions to determine the
varying levels of Ser/Thr/Tyr phosphorylation events. However,
the issues associated with SILAC when applied to bacteria
are well documented (Soufi and Macek, 2014) and include, in
particular, cases such as mycobacteria where there is no available
viable, lysine-deficient mutant. Alternatively, chemical labeling,
such as peptide demethylation labeling (Boersema et al., 2009),
has been proven a convenient and efficient method to obtain
differential quantification of bacterial PTMs (Spat et al., 2015;
De Keijzer et al., 2016) and has gained increasing popularity.
Additionally, an always attractive quantitative approach is label
free quantification (LFQ), which has been applied on a number
of occasions to further investigate the different PTMs levels
in bacteria. Within this context, although phospho-enrichment
strategies combined with LFQ analyses look promising, it has
been pointed out (Rosenberg et al., 2015) that low occupancy
among bacterial phosphorylation events may compound possible
inconsistences amongst biological replicates.
MS based detection of PTMs is normally based on a mass
shift introduced by the site-specific modification, however these
are often sub-stoichiometric and usually occur at low abundance,
thus an enrichment process (such as those mentioned above) is
typically carried out for a specific PTM prior to subsequent MS
analysis. The enrichment steps are however, for many, a major
drawback in bacterial PTM analyses, since the enrichment step
typically requires large amounts of starting material including
protein concentrations in the order of 5–9mg (Soufi et al.,
2008; Soares et al., 2013, 2014; Spat et al., 2015). While this is
can be easily achieved when using liquid cell culture, this may
represent amajor technical challenge for other studies, such those
looking at host pathogen interactions at the site of infection,
where it is virtually impossible to isolate the large number of
bacterial cells or the physical amount of protein needed in
those protocols. Additionally, the multiple rounds of enrichment
steps remain a source of possible technical variations that can
bias downstream quantitative analyses. Ultimately, the efficiency
and reproducibility of the enrichment protocol across multiple
samples is determinant both in terms of coverage as well as in
terms of accurate quantification.
MS BASED TARGETED METHODOLOGIES
WILL ALLOW DETECTION AND
QUANTIFICATION OF LOW ABUNDANT
BACTERIAL PTMS
Emerging targeted MS methodologies, namely selected reaction
monitoring (SRM), and parallel reaction monitoring (PRM),
appear as perhaps the latest breakthrough within the field.
Specifically, targeted mass spectrometry offers unequaled
capability to characterize and quantify a specific set of
proteins/peptides reproducibility, in any biological sample.
In this hypothesis-driven approach (Picotti et al., 2013), only a
small number of peptides are used as surrogate markers for the
protein of interest, which are selectively measured in predefined
m/z ranges and retention time windows. SRM (often called
MRM, multiple reaction monitoring) is a targeted approach
to quantitate pre-selected peptides by monitoring specific
precursor-to-product ion transitions in a triple-quadrupole
mass spectrometer (Picotti et al., 2010, 2013). While SRM
measurements use a low resolution MS instrument, PRMs
alternatively benefit from the capabilities of high resolution
quadrupole and Orbitrap analysers (Peterson et al., 2012). The
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increased quality of hybrid quadrupole-Orbitrap analyses has
consequently improved the quality of the target methods, mainly
in terms of accuracy at the level of fragment, which enables the
fundamental distinction of target compounds from the undesired
background ions and enables a significantly lowered detection
limit. In mammalian systems, SRM assays have been successfully
applied in a large scale targeted proteomics experiment of a
phosphorylation network. In the first of its kind study, Wolf-
Yadlin et al. (2007) applied SRM to monitor the dynamics over
time of tyrosine phosphorylation events in EGFR signaling
after EGF stimulation. The authors used a combination of
iTRAQ peptide labeling and phosphotyrosine peptide immune-
purification coupled with IMAC to enrich for phosphotyrosine
containing peptides (Wolf-Yadlin et al., 2007). More recently,
Adachi et al. (2016) described the application of a large-scale
phosphoproteome analysis and SRM-based quantification to
develop a strategy for the systematic discovery and validation
of biomarkers. Their two step approach described uses a
typical IMAC based phosphoenrichment coupled to shotgun
MS-based proteomic analysis in order to identify differentially
modulate phosphopeptides; identified candidates are then
validated by SRM analysis (Adachi et al., 2016). In another
recent, well-designed application, Altelaar and co-workers
suggested a strategy to monitor signal transduction pathways:
By combining targeted quantitative proteomics with high
selective phosphopeptide enrichment, the authors monitored
the phosphorylation dynamics of the PI3K-mTOR and MAPK
signaling network (De Graaf et al., 2015). Interestingly, in
order to increase the success rate of the phosphopeptide
SRM assays the authors focused on phosphopeptides reported
previously by the group and from publicly available shotgun
proteomics experimental data. The rationale for this approach
is that phosphorylation alters the local charge distribution,
which may interfere with proteolytic cleavage, thus previous
knowledge of the phosphosite would enable a more efficient
SRM assay. The study used synthetic stable isotope standard
phosphopeptides for increased accuracy in quantification (De
Graaf et al., 2015). Despite all this, measuring PTMs events
through SRM can be challenging and in most cases involves time
consuming assay optimization and reliance on synthetic peptide
standards (Lawrence et al., 2016), which can be somewhat
discouraging in practice. However, recently Lawrence et al.
have proposed the use of PRMs as a straightforward and
efficient means for large-scale targeted phosphoproteomic
analysis. Here, instead of using databases of previously reported
human phosphopeptide sequences, the authors report a highly
comprehensive shotgun global phosphoproteomic analysis
that resulted in the identification of more than 7.5 million
phosphopetide spectral matches corresponding to 109,611
phosphorylation sites (Lawrence et al., 2016). Subsequently, the
authors used the generated information, including the respective
phosphopeptides retention times, to develop a plug-and-play
phosphoproteomic system, based on sets of targeted, label-
free phosphopeptide PRM assays in order to interrogate the
dynamics of the IGF1/AKT signaling pathway. Importantly,
the study demonstrated that without sample fractionation and
or phosphopeptide enrichment (Lawrence et al., 2016), PRM
label-free quantification assays is a rapid assay for measuring
virtually any known phosphorylation event in the human
species.
Targeted methodologies have been successfully applied to
investigate aspects of the pathogenic bacteria proteome (Lange
et al., 2008; Karlsson et al., 2012; Schubert and Aebersold,
2015; Schubert et al., 2015; Peters et al., 2016). A noteworthy
highlight is that Ruedi Aebersold and colleagues have recently
generated a library of targeted SRM assays for ∼97% of the
4012 annotated Mycobacterium tuberculosis proteins and were
able to reproducibly quantify ∼72% of the theoretical M.
tuberculosis proteome in single unfractionated runs on a triple
quadrupole MS (Schubert et al., 2013). As such, the generatedM.
tuberculosis proteome library represents a valuable experimental
resource that now in theory enables researchers to interrogate
and quantify essentially the entire proteome of M. tuberculosis
in a single experiment. This allows for greater understanding
of, for example, differences in expressed pathogenicity and
virulence between clinical isolates. However, in order to further
investigate mycobacterial or any other bacterial PTMs in a large
scale, targeted and quantitative manner, it will be necessary
first to follow a workflow similar to that used in mammalian
cells as suggested by Lawrence et al. (2016). A strategy based
on previous knowledge of the post translationally modified
proteins/peptide is sensitive enough to detect low abundance,
modified peptides. To date, much of the work on pathogenic
bacteria using MS-based proteomics has focused on cataloging,
and in some cases quantifying, PTMs that occur under in vitro
conditions. Although informative, such reports come with the
caveat of the studied conditions often being detached from the
unique microenvironment that pathogenic bacteria are exposed
to during host infection and/ or during colonization (e.g.,
inside the macrophage). Thus, in order to gain meaningful
insights into the dynamics and role of different bacterial PTMs
during host-pathogen interactions, it is crucial that researchers
in the field join efforts to once again take advantage of recent
advances in mass spectrometry instrumentation and develop
targeted, quantitative PTM workflows that enable detection and
accurate quantification of low-abundance, modified analytes,
ideally circumventing the need for additional PTM enrichment
steps in the process.
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